Hematologic disorders comprise a vast category of diseases that affect millions of Americans and have a significant impact on the lives of individuals, their loved ones and the U.S. healthcare system ...
Hematologic malignancy patients face high COVID-19 risk, with 23.5% experiencing severe illness despite vaccination. Mortality rate was 22.4%, influenced by age, active disease, and ICU admission.
Hematopoietic Stem-Cell Transplantation: Exploring the Latest Advances and Gaps in Disparities, Psychosocial and Symptom Management Interventions, and Chronic Graft-Versus-Host Disease Care Although ...
A new report in The Lancet Haematology, led by Cleveland Clinic hematologist Bethany Samuelson Bannow, M.D., outlines ...
The US Food and Drug Administration (FDA) on Thursday finalized guidance on the nonclinical studies drugmakers should conduct when developing products to treat severely debilitating or ...
Early longitudinal specialist-delivered inpatient palliative care for patients with AML and those undergoing HSCT has been shown to decrease anxiety, depression, and post traumatic stress disorder ...
A new report in The Lancet Haematology, led by Cleveland Clinic hematologist Bethany Samuelson Bannow, M.D., outlines practical strategies to improve diagnosis, care and outcomes globally for women ...
Announcing a new article publication for Zoonoses journal. Hematologic disorders occur frequently in patients with Ebola virus disease (EVD) and are characterized by one or several abnormalities in ...
Older patients often face financial challenges on fixed incomes with different payer systems like Medicare, Sarah Wall, MD, The Ohio State University Comprehensive Cancer Center, says. Accessing ...
Healthcare Asia Magazine on MSN
Abu Dhabi to launch rare diseases centre of excellence
It will serve as a flagship hub for diagnosis, amongst others. The Department of Health – Abu Dhabi (DOH), AstraZeneca and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results